Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 22;13(6):676-687.
doi: 10.1039/d2md00027j. eCollection 2022 Jun 22.

A story of peptides, lipophilicity and chromatography - back and forth in time

Affiliations
Review

A story of peptides, lipophilicity and chromatography - back and forth in time

Vanessa Erckes et al. RSC Med Chem. .

Abstract

Peptides, as part of the beyond the rule of 5 (bRo5) chemical space, represent a unique class of pharmaceutical compounds. Because of their exceptional position in the chemical space between traditional small molecules (molecular weight (MW) < 500 Da) and large therapeutic proteins (MW > 5000 Da), peptides became promising candidates for targeting challenging binding sites, including even targets traditionally considered as undruggable - e.g. intracellular protein-protein interactions. However, basic knowledge about physicochemical properties that are important for a drug to be membrane permeable is missing but would enhance the drug discovery process of bRo5 molecules. Consequently, there is a demand for quick and simple lipophilicity determination methods for peptides. In comparison to the traditional lipophilicity determination methods via shake flask and in silico prediction, chromatography-based methods could have multiple benefits such as the requirement of low analyte amount, insensitivity to impurities and high throughput. Herein we elucidate the role of peptide lipophilicity and different lipophilicity values. Further, we summarize peptide analysis via common chromatographic techniques, in specific reversed phase liquid chromatography, hydrophilic interaction liquid chromatography and supercritical fluid chromatography and their role in drug discovery and development process.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts to declare.

Figures

None
Vanessa Erckes
None
Christian Steuer

References

    1. Henninot A. Collins J. C. Nuss J. M. J. Med. Chem. 2018;61:1382–1414. doi: 10.1021/acs.jmedchem.7b00318. - DOI - PubMed
    1. Lau J. L. Dunn M. K. Bioorg. Med. Chem. 2018;26:2700–2707. doi: 10.1016/j.bmc.2017.06.052. - DOI - PubMed
    1. D'Aloisio V. Dognini P. Hutcheon G. A. Coxon C. R. Drug Discovery Today. 2021;26:1409–1419. doi: 10.1016/j.drudis.2021.02.019. - DOI - PubMed
    1. Scott D. E. Bayly A. R. Abell C. Skidmore J. Nat. Rev. Drug Discovery. 2016;15:533–550. doi: 10.1038/nrd.2016.29. - DOI - PubMed
    1. Philippe G. J. B. Craik D. J. Henriques S. T. Drug Discovery Today. 2021;26:1521–1531. doi: 10.1016/j.drudis.2021.01.022. - DOI - PubMed